Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etravirine Safety and PK in Treatment-Experienced HIV-1
NCT01422330Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2011
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 4 trial of etravirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen Pharmaceutical. Started Sep 2011; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01422330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422330.